Clin2
NCT04813159Possibly a fitRecruiting

Remote heart preconditioning for people with blocked-heart-attack

STEMIRemote Ischaemic ConditioningMyocardial Reperfusion Injury

Part of Heart & circulation clinical trials.

This study tests whether a remote, arm-based treatment done around the time of a heart attack can improve outcomes in people with STEMI (a serious heart-attack type). Some participants receive the real treatment and some receive a sham version, while others may be followed observationally depending on how long ago symptoms started.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,400 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older and having a STEMI (a specific heart-attack pattern on ECG) confirmed by the study team.
  • Your most severe chest pain started within 72 hours (either within 24 hours for the randomized part, or 24–72 hours for the observation part).
  • If you are in the randomized group: you must be within 24 hours of the chest-pain start and able to sign consent.
  • You should NOT be planned for primary angioplasty/stent placement (primary percutaneous coronary intervention).
  • You should not have very unstable circulation/shock, serious signs of organ stress (like low urine, confusion, or high lactate), or conditions that prevent using the arm treatment (like severe active arm burns, acute arm poor circulation, gangrene, or certain arm vessel access problems).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07082153Not yet recruiting
Coronary sinus balloon pump for heart attack patients

This trial tests a new device that may help support the heart during emergency treatment for a severe heart attack. It is for patients who have had symptoms for 6 to 24 hours and have a weakened heart muscle.

NCT07293832Recruiting
Beta-blocker therapy for heart attack patients

This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).

Thessaloniki, Thessaloniki
NCT04775914Recruiting
Test a heart procedure guide during emergency STEMI treatment

This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.

Copenhagen, Capital Region
NCT03787745Recruiting
Testing a heart-protection method after a blocked-artery procedure

This study looks at whether “ischemic postconditioning” (briefly changing blood flow right after opening a blocked heart artery) can improve outcomes in people with a specific type of heart attack. It’s meant for patients who get primary PCI (a catheter-based procedure to reopen the artery) soon after symptoms start.

Copenhagen
NCT07171580Not yet recruiting
Remote heart attack recovery education at home

This trial tests a remote education and support program to help people recover after a heart attack using digital tools from home, instead of in-person visits. It may be a good fit if you are comfortable with technology and live in Manitoba.

Winnipeg, Manitoba
NCT07237542Recruiting
Remote ischemic preconditioning for small stroke prevention

This study tests whether a simple, non-invasive treatment called remote ischemic preconditioning (using brief periods of blood pressure cuff inflation on the arm) can help prevent early neurological worsening in people who have had a small, specific type of stroke. It may offer a safe way to protect your brain while you recover.

Nanjing, Jiangsu

Hear when a new STEMI trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.